ESTRELLA IMMUNOPHARMA, INC. Operating Leases, Rent Expense
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Operating Leases, Rent Expense of $6.00 thousand for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2024-02-14
- ESTRELLA IMMUNOPHARMA, INC. operating leases, rent expense for the quarter ending 2023-12-31 was $6.00K, a 0.00% change year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. operating leases, rent expense for the quarter ending 2023-09-30 was $2.00K, a 66.67% decline year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. operating leases, rent expense for the quarter ending 2022-12-31 was $6.00K.
- ESTRELLA IMMUNOPHARMA, INC. operating leases, rent expense for the quarter ending 2022-09-30 was $6.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month |
|---|---|---|
| 2023-12-31 | $6.00K 10-Q · filed 2024-02-14 | $8.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-20 | |
| 2022-12-31 | $6.00K 10-Q · filed 2024-02-14 | $10.00K 10-Q · filed 2024-02-14 |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |